Related references
Note: Only part of the references are listed.Mechanism of metformin action in MCF-7 and MDA-MB-231 human breast cancer cells involves oxidative stress generation, DNA damage, and transforming growth factor β1 induction
Poliana Camila Marinello et al.
TUMOR BIOLOGY (2016)
Metformin in Cancer Treatment and Prevention
Daniel R. Morales et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway
Baiyu Han et al.
TUMOR BIOLOGY (2015)
Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile
Cristina Oliveras-Ferraros et al.
CELL CYCLE (2014)
Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle
S. M. Hadad et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2014)
Metformin Does Not Affect Cancer Risk: A Cohort Study in the UK Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial
Konstantinos K. Tsilidis et al.
DIABETES CARE (2014)
AMP-Activated Protein Kinase Is Required for Cell Survival and Growth in HeLa-S3 Cells In Vivo
Xuhong Song et al.
IUBMB LIFE (2014)
Metformin reverses multidrug resistance and epithelial-mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells
Chen Qu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Metformin Induces Apoptosis and Cell Cycle Arrest Mediated by Oxidative Stress, AMPK and FOXO3a in MCF-7 Breast Cancer Cells
Eveline A. I. F. Queiroz et al.
PLOS ONE (2014)
Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors
Mark E. Welker et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Association of metformin use with cancer incidence and mortality: A meta-analysis
Pengpeng Zhang et al.
CANCER EPIDEMIOLOGY (2013)
Snail/beta-catenin signaling protects breast cancer cells from hypoxia attack
Alexander M. Scherbakov et al.
EXPERIMENTAL CELL RESEARCH (2013)
Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
Michael Cerezo et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Lipid raft-mediated Akt signaling as a therapeutic target in mantle cell lymphoma
M. Reis-Sobreiro et al.
BLOOD CANCER JOURNAL (2013)
Does Metformin affect ER, PR, IGF-1R, β-catenin and PAX-2 expression in women with diabetes mellitus and endometrial cancer?
Anna Markowska et al.
DIABETOLOGY & METABOLIC SYNDROME (2013)
Metformin and the Risk of Cancer Time-related biases in observational studies
Samy Suissa et al.
DIABETES CARE (2012)
The mTOR Signalling Pathway in Human Cancer
Helena Populo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
The relationships between snail1 and estrogen receptor signaling in breast cancer cells
Alexander M. Scherbakov et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells
Lev M. Berstein et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner
R. Rattan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy
A. Vazquez-Martin et al.
ANNALS OF ONCOLOGY (2009)
Histological evaluation of AMPK signalling in primary breast cancer
Sirwan M. Hadad et al.
BMC CANCER (2009)
Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ER alpha negative MDA-MB-435 breast cancer model
Kathryn N. Phoenix et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer
K. Lundgren et al.
BRITISH JOURNAL OF CANCER (2009)
Metformin induces unique biological and molecular responses in triple negative breast cancer cells
Bolin Liu et al.
CELL CYCLE (2009)
A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-β mediated epithelial-mesenchymal transition
Theresa Vincent et al.
NATURE CELL BIOLOGY (2009)
Rearrangements of the Actin Cytoskeleton and E-Cadherin-Based Adherens Junctions Caused by Neoplasic Transformation Change Cell-Cell Interactions
Dmitry V. Ayollo et al.
PLOS ONE (2009)
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Mahvash Zakikhani et al.
CANCER RESEARCH (2006)
Activation of mitogenic pathways and sensitization to estrogen-induced apoptosis: two independent characteristics of tamoxifen-resistant breast cancer cells?
Alexander M. Scherbakov et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Efficient production of human FVIII in hemophilic mice using lentiviral vectors
NA Kootstra et al.
MOLECULAR THERAPY (2003)
Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling
G Reid et al.
MOLECULAR CELL (2003)
Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway
GA Ruiter et al.
ANTI-CANCER DRUGS (2003)
Share Paper
